Hexagon Health Sues Medtronic for Alleged Patent Infringement on Hernia Mesh Technology

14 November 2024 | Thursday | News

Hexagon Health sues Medtronic, alleging the giant couldn’t resist ‘borrowing’ their patented hernia repair tech for Dextile, sparking yet another ‘whoops, we did it again’ moment for the multinational.
Picture Courtesy | Public Domain

Picture Courtesy | Public Domain

The suit alleges Medtronic violated Hexagon Health's patents in developing and selling Dextile, a hernia mesh repair device.

 Hexagon Health Inc. and its founder Dr. Shirin Towfigh, one of the world's leading hernia repair surgeons, filed a lawsuit in Delaware today against Medtronic, alleging that the multinational medical device manufacturer infringed three of Hexagon Health's patents related to hernia mesh treatment devices.

The lawsuit asserts that Medtronic copied Hexagon Health's designs for an inguinal hernia mesh repair device, known as Dextile, that includes broad coverage with a fin shape to better serve patients and reduce complications following surgery. The suit further charges that Medtronic knowingly continued to manufacture and sell the device even after the U.S. Patent Office formally awarded Hexagon Health's patents on Dr. Towfigh's improved mesh.

"Medtronic's improper use of Hexagon Health's hernia mesh designs has cost Dr. Towfigh significant financial gain and created a disincentive for other physician-entrepreneurs to enter the medical device marketplace with innovative products for patients in need," said Nicholas Groombridge, Hexagon Health's attorney and partner at Groombridge, Wu, Baughman & Stone LLP. "Medtronic has a history of infringing patents and failing to honor agreements with physician-inventors, and we look forward to addressing this matter in court." 

Dr. Towfigh is an experienced surgeon and a leading expert on hernia care. She founded Hexagon Health in 2015 to revolutionize hernia care and protect patients from surgical hernia complications. Her re-designed inguinal hernia mesh device ensures broad coverage of the groin area to reduce hernia complications for patients, particularly, women, for whom inguinal hernias can be fatal.

 

Survey Box

Poll of the Week

Which area of biopharmaceutical research excites you the most?

× Please select an option to participate in the poll.
Processing...
× You have successfully cast your vote.
 {{ optionDetail.option }}  {{ optionDetail.percentage }}%
 {{ optionDetail.percentage }}% Complete
More polls
Stay Connected

Sign up to our free newsletter and get the latest news sent direct to your inbox

© 2024 Biopharma Boardroom. All Rights Reserved.

Show

Forgot your password?

Show

Show

Lost your password? Please enter your email address. You will receive a link to create a new password.

Back to log-in

Close